Glenmark Pharmaceuticals is set to trade ex-dividend this week, with an interim dividend of Rs 2.5 per share. Here’s what Indian investors need to know about the ex-dividend date, record date, and eligibility criteria.
Get the latest updates on the RBI’s MPC meeting, Trump’s 100% import tax on pharmaceutical drugs, and a slew of IPOs lined up for the week ahead, and how they may impact Indian investors.
The Indian primary market is witnessing a surge in initial public offerings, with 20 IPOs set to open for subscription next week. Get the full list of upcoming IPOs and expert analysis.
Laser Power and Infra Ltd. has filed preliminary papers with SEBI to raise Rs 1,200 crore through an IPO, targeting a valuation of Rs 5,500-6,500 crore. Here’s what Indian investors should know about the company and its plans.
Paushak Ltd. and Sumeet Industries Ltd. have announced their record dates for upcoming stock splits. Find out how this affects investors and what to expect.
Indo MIM, a leading precision components maker, has filed preliminary papers with SEBI to raise Rs 1,000 crore through an initial public offering (IPO).
NTPC is set to appoint a consultant to identify uranium mines overseas, marking a significant step in its nuclear energy expansion plans. Get the latest updates on India’s power sector and NTPC’s strategic moves.
CSM Technologies, a leading digital transformation and GovTech company, has filed its draft IPO papers with SEBI to raise funds through a fresh issue of equity shares. Here’s what Indian investors need to know.
Glenmark, Granules India, Zydus, and other Indian drugmakers are recalling products in the US market due to manufacturing issues. Find out what this means for investors and the Indian pharmaceutical industry.
GEE Ltd, Paushak Ltd, and Shilpa Medicare Ltd are set to disburse bonus shares to their stakeholders. Find out the record date, bonus share ratio, and eligibility criteria for these companies.